期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 9, 期 13-14, 页码 1509-1517出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2009.09.003
关键词
SM934; Artemisinin; TCR; IL-2; T lymphocytes; Apoptosis; Akt; Delayed type hypersensitivity
资金
- Shanghai Science and Technology Committee [08XD14053, 06DZ19006, 08DZ1980200]
- Chinese Academy of Science [SIMM0709QN-01]
- national key scientific and technological project [2009ZX09102-019]
In the present study, we investigated the immunosuppressive effects and underlying mechanisms of aminoarteether maleate (SM934), a derivative of artemisinin, against T cell activation in vitro and in vivo. In vitro, SM934 significantly inhibited the proliferation of splenocytes induced by concanavalin A (Con A), lipopolysaccharide (LPS), mixed lymphocyte reaction (MLR), and anti-CD3 plus anti-CD28 (anti-CD3/28). SM934 significantly inhibited interferon (IFN)-gamma production and CD4(+) T cell division stimulated by anti-CD3/28. SM934 also promoted apoptosis of CD69(+) population in CD4(+) T cells stimulated by anti-CD3/28. Furthermore, SM934 inhibited interleukin (IL)-2 mediated proliferation and survival through blocking Akt phosphorylation in activated T cells. In ovalbumin (OVA)-immunized mice, oral administration of SM934 suppressed OVA-specific T cell proliferation and IFN-gamma production. SM934 treatment also significantly inhibited the sheep red blood cell (SRBC)-induced delayed type hypersensitivity (DTH) reactions in mice. Taken together, SM934 showed potent immunosuppressive activities in vitro and in vivo. Our results demonstrated that SM934 might be a potential therapeutic agent for immune-related diseases. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据